Shortage expected to last until at least June 30, according to the American Hospital Association
Consider COVID Vax History When Assessing Adenopathy on Mammo
Axillary lymphadenopathy more likely within 14 days after vaccination; persistent axillary lymphadenopathy seen up to 43 weeks later
AI System Can Predict Deterioration in COVID-19 Patients in ED
System that uses chest X-ray images, clinical variables had area under the curve of 0.786 for predicting deterioration in 96 hours
Guidelines Provided for Unilateral Lymphadenopathy After COVID-19 Vaccination
In most clinical settings, ipsilateral UAL after recent COVID-19 vaccination is benign finding; clinical follow-up recommended
Inflammatory Heart Disease After COVID-19 Rare in Athletes
Five athletes (0.6 percent) had cardiac magnetic resonance imaging findings suggestive of inflammatory heart disease
Axillary Adenopathy Reported After Recent COVID-19 Vaccination
Management approach to these findings includes axillary ultrasound if clinical concern persists six weeks after final dose of vaccine
Pandemic Has Disrupted Lung Cancer Screenings
Once operations resumed, decrease seen in new patients screened, proportion of suspicious nodules increased
RSNA: Neurologic Complications of COVID-19 Examined
In patients with critical findings identified on neuroimaging, most common comorbidities were hypertension, diabetes